Barzolvolimab
巴佐利单抗
Report date: 2026/05/02 20:00:18
Base Information
Drug NameBarzolvolimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[37]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesYale UniversityUniversity Of Toronto - St. George Campus
China Registration ClassN/A
Develop Information
Active CompaniesCelldex Therapeutics
Inactive CompaniesN/A
Active Indications +[7]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A